跳转到内容

Upjohn

维基百科,自由的百科全书
The Upjohn Company
公司類型公司 编辑维基数据
公司結局Pharmacia合并为Pharmacia & Upjohn
後繼機構Pharmacia & Upjohn
晖致(Viatris)
成立1886年 (1886)
结束1995年,​31年前​(1995
總部美国密歇根州波蒂奇
产业制药产业
Upjohn的早期Logo

Upjohn是一家美国制药公司,1886年由威廉·E·厄普约翰密歇根州黑斯廷斯成立[1],1995年与瑞典Pharmacia公司合并为Pharmacia & Upjohn,现为輝瑞公司所有。

历史

[编辑]

1976年,公司的三位科学家开发了Upjohn双羟基化反应[2]

产品

[编辑]

四位数

[编辑]
名称 CAS号 分子式 化学结构
苄非他明
(U-0441)
156-08-1 C
17
H
21
N
U-0882 310-35-0 C
18
H
21
NO
2
敌鼠
(U-1363)
82-66-6 C
23
H
16
O
3
羧雌醚
(U-2911)
1755-52-8 C
17
H
22
O
3
U-4527 66-81-9 C
15
H
23
NO
4
U-5956 480-49-9 C
35
H
58
O
11
U-6040 76-43-7 C
20
H
29
FO
3
U-6056 13117-35-6 C
13
H
18
N
2
U-8113 1688-71-7 C
10
H
13
NO
U-8344 66-75-1 C
8
H
11
Cl
2
N
3
O
2
U-8471 2668-66-8 C
22
H
32
O
3
U-8614 426-13-1 C
22
H
29
FO
4
醋酸甲羥孕酮
(U-8839)
71-58-9 C
24
H
34
O
4
U-8840 520-85-4 C
22
H
32
O
3
2-氨基-1,1,3-三氰基-1-丙烯
(U-9189)
868-54-2 C
6
H
4
N
4
U-9889 18883-66-4 C
8
H
15
N
3
O
7

五位数

[编辑]
名称 CAS号 分子式 化学结构
U-10157 705-62-4 C
9
H
12
N
2
S
米勃龙 (U-10997)[3] 3704-09-4 C
20
H
30
O
2
U-11000A 1845-11-0 C
29
H
31
NO
2
U-11555A 64-96-0 C
28
H
31
NO
2
曲托龙 (U-11828)[3] 3764-87-2 C
19
H
28
O
2
U-12504 1228-19-9 C
13
H
18
ClN
3
O
3
S
U-17312E 2235-90-7 C
12
H
16
N
2
U-17323 3801-06-7 C
24
H
31
FO
5
U-17835 1156-19-0 C
14
H
21
N
3
O
3
S
勃拉睾酮
(U-19763)
1605-89-6 C
21
H
32
O
2
吲哚克索維基數據Q27286852
(U-22020)
5034-76-4 C
22
H
19
NO
2
U-22,410A 10090-61-6 C
28
H
29
NO
卡鲁睾酮
(U-22550)
17021-26-0 C
21
H
32
O
2
U-23284 18771-50-1 C
9
H
16
N
2
O
6
U-23,469[4] 36840-93-4 C
26
H
28
O
4
U-24,568 21766-17-6 C
26
H
22
N
2
O
2
U-26,597A 8001-95-4 C
11
H
28
ClN
5
O
U-28288D 22195-34-2 C
10
H
19
N
3
O
2
2-MDP英语2-MDP
(U-23807A)
33887-05-7 C
16
H
19
NO
U-28,774 27223-35-4 C
20
H
17
ClN
2
O
3
U-29409 31785-60-1 C
18
H
14
N
2
O
U-30870 50303-11-2 C
23
H
31
NO
2
骨化二醇 (U-32070) 19356-17-3 C
27
H
44
O
2
U-31,355 99983-92-3 C
11
H
10
ClN
3
S
U-32802A 36735-48-5 C
22
H
23
F
2
NO
U-33030 28911-01-5 C
17
H
12
Cl
2
N
4
U-35,777A 55199-71-8 C
23
H
27
F
2
NO
2
U-37883A 57568-80-6 C
21
H
35
N
3
O
U-41792 56714-70-6 C
21
H
29
NO
U-42585 53882-12-5 C
11
H
6
ClN
3
O
6
U-46619 56985-40-1 C
21
H
34
O
4
U-46785 61263-35-2 C
23
H
38
O
4
U-47109 67579-13-9 C
15
H
20
Cl
2
N
2
O
U-47,476A 36192-18-4 C
12
H
18
N
2
U-47700 82657-23-6 C
16
H
22
Cl
2
N
2
O
溴朵林
(U-47931E)
67579-24-2 C15H21BrN2O
U-48520 67579-11-7 C
16
H
23
ClN
2
O
依氯那明
(U-48753)
67450-44-6 C
16
H
22
Cl
2
N
2
O
U-48800 2370977-17-4 C
17
H
24
Cl
2
N
2
O
U-49900 67579-76-4 C
18
H
26
Cl
2
N
2
O
U-50211 98587-47-4 C
16
H
24
N
2
O
2
U-50488 67198-13-4 C
19
H
26
Cl
2
N
2
O
U-51574 PubChem CID:44269303 C
17
H
24
Cl
2
N
2
O
U-52047 71628-96-1 C
28
H
31
NO
10
U-53059 70529-35-0 C
18
H
14
F
3
NO
2
S
U-54669F 72141-57-2 C
27
H
22
F
4
N
4
O
3
S
U-57700 102092-12-6 C
16
H
21
N
U-57930E 79548-73-5 C
17
H
31
ClN
2
O
5
S
U-58838 83701-22-8 C
9
H
15
N
5
O
4
S
吡前列素維基數據Q27287941
(U-60257)
79672-88-1 C
26
H
35
NO
4
U-61,431F 81845-44-5 C
22
H
36
O
4
螺朵林英语Spiradoline
(U-62066)
87151-85-7 C
22
H
30
Cl
2
N
2
O
2
U-63557A 85666-24-6 C
15
H
11
NO
3
U-64279E 104010-37-9 C
19
H
17
N
5
O
7
S
3
阿仑替莫
(U-66444B)
112892-81-6 C
19
H
25
NO
U-69167 99499-40-8 C
16
H
17
N
3
OS
2
U-69593 96744-75-1 C
22
H
32
N
2
O
2
U-73122 112648-68-7 C
29
H
40
N
2
O
3
U-73343 142878-12-4 C
29
H
42
N
2
O
3
U-74006 110101-66-1 C
38
H
52
N
6
O
2
U-75875 (Pnu-75875) 112190-24-6 C
45
H
61
N
7
O
7
U-77891 119878-31-8 C
18
H
24
Br
2
N
2
O
U-78036 123742-98-3 C
17
H
11
ClN
2
O
U-78875 124423-84-3 C
18
H
17
N
5
O
2
卡折来新維基數據Q27263977
(U-80244)
119813-10-4 C
41
H
37
ClN
6
O
5
U-80493 136816-67-6 C
21
H
30
N
4
O
U-81749 126103-94-4 C
33
H
56
N
4
O
4
U-82208E 136591-56-5 C
20
H
36
N
2
O
3
S
U-82209E 136591-58-7 C
20
H
36
N
2
O
3
S
U-84569 130736-25-3 C
25
H
23
NO
4
U-86983 130736-65-1 C
19
H
18
N
2
O
4
阿替韦啶
(U-87201E)
138540-32-6 C
21
H
25
N
5
O
2
U-88779E 149539-01-5 C
29
H
33
ClN
2
O
2
U88999E 142223-57-2 C
29
H
32
F
2
N
2
O
2
U-89360E 161897-65-0 C
28
H
52
N
8
O
6
U-90152 136817-59-9 C
22
H
28
N
6
O
3
S
U-92032 142223-92-5 C
30
H
35
F
2
N
3
O
2
U-92798 PC9891838 C
30
H
34
F
2
N
2
O
2
U-96988 149394-65-0 C
24
H
26
O
3
U-99194 82668-33-5 C
17
H
27
NO
2
U-99363 179556-82-2 C
20
H
27
N
3
O

六位数

[编辑]
名称 CAS号 分子式 化学结构
U-100480 168828-58-8 C
16
H
20
FN
3
O
3
S
U-101387 170858-33-0 C
21
H
27
N
3
O
3
S
U-101958 170856-57-2 C
21
H
29
N
3
O
U-103017 166335-18-8 C
28
H
28
N
2
O
5
S

参考文献

[编辑]
  1. ^ Lohrstorfer, Martha; Larson, Catherine. William E. Upjohn: Person of the Century 1853 - 1932. Kalamazoo Public Library. 2002 [December 24, 2024]. (原始内容存档于May 17, 2008). Known by his contemporaries as a dreamer and a tinkerer, Dr. Upjohn saw a need to improve the means of administering medicine. Most medicines of the day were in fluid form, and those in pill form were often hard and insoluble. Patients were left to try to digest the bitter medicine, with no guarantee that it would dissolve in their systems effectively. Dr. Upjohn began experimenting with making better pills in the attic of his home. Eventually he invented his "friable" pill. Friable meant that the pill could easily be crushed to a powder. The pill was patented in 1885, and its reputation quickly spread within the medical community, thanks greatly to Dr. Upjohn's marketing strategy. He sent small pine boards to thousands of physicians along with samples of his rival's hard pills, and his own friable pills. He invited doctors to hammer the pills into the boards to see which one would be the most digestible. This tactic was eventually modified, but for the next 60 years, a thumb reducing an Upjohn pill to powder was used as the trademark symbol of his company, the Upjohn Pill and Granule Company, later more widely known to the world as The Upjohn Company. 
  2. ^ VanRheenen, V.; Kelly, R.C.; Cha, D.Y. An improved catalytic OsO4 oxidation of olefins to -1,2-glycols using tertiary amine oxides as the oxidant. Tetrahedron Letters. 1976-06, 17 (23): 1973–1976. doi:10.1016/S0040-4039(00)78093-2. 
  3. ^ 3.0 3.1 ((Lyster, S C.)), ((Duncan, G W.)). ANABOLIC, ANDROGENIC AND MYOTROPIC ACTIVITIES OF DERIVATIVES OF 7α-METHYL-19-NORTESTOSTERONE. Acta Endocrinologica. July 1963, 43 (3): 399–411. doi:10.1530/acta.0.0430399.  温哥华格式错误 (帮助)
  4. ^ ((Castañer, J.)), ((Hillier, K.)). U-23,469. Drugs of the Future. 1980, 5 (11): 564. ISSN 0377-8282. doi:10.1358/dof.1980.005.11.1002363. 

外部链接

[编辑]